VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 112 filers reported holding VISTAGEN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $159 | -69.7% | 1,275,215 | -75.0% | 0.02% | -75.4% |
| Q4 2022 | $525 | -99.9% | 5,095,354 | -2.4% | 0.06% | -38.1% |
| Q3 2022 | $794,000 | +556.2% | 5,222,292 | +3686.0% | 0.10% | +483.3% |
| Q2 2022 | $121,000 | +31.5% | 137,938 | +86.5% | 0.02% | +50.0% |
| Q1 2022 | $92,000 | +4.5% | 73,969 | +131.3% | 0.01% | +33.3% |
| Q3 2021 | $88,000 | – | 31,984 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |